Physician profile
Lawrence R Bachle
NPI 1114978343
$3,882.07
in general payments reported to CMS, 2019-2025
11 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Undersea and Hyperbaric Medicine (Emergency Medicine) provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $987 · 2020: $616 · 2021: $580 · 2022: $503 · 2023: $781 · 2024: $263 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,196.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $799.42 | 2019-2021 | |
| Organogenesis INC. | $738.08 | 2019-2023 | Puraply |
| Next Science LLC | $592.32 | 2023 | Blastx, Xperience, Surgx |
| Paratek Pharmaceuticals, INC. | $579.13 | 2021-2024 | Nuzyra |
| Smith+Nephew, INC. | $571.30 | 2019-2025 | Grafix Pl, Grafix, Collagenase Santyl |
| Integra Lifesciences Corporation | $164.58 | 2019-2020 | |
| Osiris Therapeutics INC. | $125.00 | 2019 | |
| Bioventus LLC | $119.85 | 2022 | |
| Boston Scientific Corporation | $91.42 | 2020 | |
| Janssen Pharmaceuticals, INC | $78.75 | 2019 | |
| Kerecis Limited | $22.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Bachle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.